Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 300Carcinoma, Non-Small-Cell Lung 246Prostatic Neoplasms 195Neoplasms 193Lung Neoplasms 151Multiple Myeloma 145Neoplasm Metastasis 110Colorectal Neoplasms 104Melanoma 97Ovarian Neoplasms 90Leukemia, Myeloid, Acute 85Pancreatic Neoplasms 75Lymphoma 75Leukemia, Lymphocytic, Chronic, B-Cell 74Brain Neoplasms 71Carcinoma, Renal Cell 67Carcinoma, Hepatocellular 62Squamous Cell Carcinoma of Head and Neck 61Lymphoma, Non-Hodgkin 60Hematologic Neoplasms 60Urinary Bladder Neoplasms 59Head and Neck Neoplasms 57Triple Negative Breast Neoplasms 55Glioblastoma 54Recurrence 52Lymphoma, Follicular 51Endometrial Neoplasms 50Uterine Cervical Neoplasms 49Stomach Neoplasms 46Sarcoma 46

Interventions

Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Gastritis, Atrophic × 90 days × Clear all
NCT02782949 2026-04-21

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
50 enrolled 10 charts
Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡